Description Of Cognitive Function In Schizophrenia Patients In The Dadi Regional Special Hospital, South Sulawesi Province

Safira Nurfabirra Dwiyanti; Saidah Syamsuddin; R. Joko Maharto; A. Suheyra Syauki; Ham Fransiskus Susanto

Authors

Safira Nurfabirra Dwiyanti Program Studi Pendidikan Profesi Dokter Umum Fakultas Kedokteran UMI
Saidah Syamsuddin Bagian Ilmu Kedokteran Jiwa Fakultas Kedokteran UMI
R. Joko Maharto Bagian Ilmu Kedokteran Jiwa Fakultas Kedokteran UMI
A. Suheyra Syauki Bagian Ilmu Kedokteran Jiwa Fakultas Kedokteran UMI
Ham Fransiskus Susanto Bagian Ilmu Kedokteran Jiwa Fakultas Kedokteran UMI

Keywords:

Schizophrenia, Cognitive Function, Gender, Education, Occupation, Type of Medication, Duration of Illness.

Abstract

Schizophrenia is a complex disorder and has a major influence on aspects of the sufferer's life with a decrease in cognitive function which is associated with poor functional outcomes. Therefore, this study aims to determine the description of cognitive function in schizophrenia sufferers at the Dadi Regional Special Hospital, South Sulawesi Province.This research was conducted using a cross-sectional approach and descriptive methods from March to April 2024 at RSKD Dadi, South Sulawesi Province. The research subjects, 113 people suffering from schizophrenia, were tested for cognitive function using the Montreal Cognitive Assessment (MoCA) test sheet.The proportion of schizophrenia patients who experience cognitive impairment at RSKD Dadi, South Sulawesi Province is 73%. Of the 73% of schizophrenia patients who experienced cognitive impairment, 53% were male, 41% had elementary school education, 57% did not work, 64% used atypical antipsychotic therapy, and 46% of patients had an illness lasting more than five years

References

WHO: Schizophrenia (2022). https://www.who.int/news-room/fact-sheets/detail/schizophrenia

Hartini, N., Fardana, N. A., Ariana, A. D., & Wardana, N. D. (2018). Stigma toward people with mental health problems in Indonesia. Psychology research and behavior management, 11, 535–541. https://doi.org/10.2147/PRBM.S175251

Lepage, M., Bodnar, M., & Bowie, C. R. (2014). Neurocognition: clinical and functional outcomes in schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 59(1), 5–12. https://doi.org/10.1177/070674371405900103

Martínez, Antón L., José Brea, Sara Rico, María Teresa de los Frailes, and María Isabel Loza. (2021). Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments. International Journal of Molecular Sciences 22, no. 18:9905. https://doi.org/10.3390/ijms22189905

Laruelle, M. (2014). Schizophrenia: from dopaminergic to glutamatergic interventions. Current opinion in pharmacology, 14, 97-102. https://doi.org/10.1016/j.coph.2014.01.001

Javitt, D.C. (2023). Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annual Review of Pharmacology and Toxicology, 63, 119-141. https://doi.org/10.1146/annurev-pharmtox-051921-093250

Zanelli, J., Mollon, J., Sandin, S., Morgan, C., Dazzan, P., Pilecka, I., ... & Reichenberg, A. (2019). Cognitive changes in schizophrenia and other psychoses in the decade following the first episode. American Journal of Psychiatry, 176(10), 811-819. https://doi.org/10.1176/appi.ajp.2019.18091088

Harvey, P. D., Bosia, M., Cavallaro, R., Howes, O. D., Kahn, R. S., Leucht, S., ... & Vita, A. (2022). Cognitive dysfunction in schizophrenia: an expert group paper on the current state of the art. Schizophrenia Research: Cognition, 29, 100249. https://doi.org/10.1016/j.scog.2022.100249

Sommer, I. E., Tiihonen, J., van Mourik, A., Tanskanen, A., & Taipale, H. (2020). The clinical course of schizophrenia in women and men—a nation-wide cohort study. NPJ schizophrenia, 6(1), 12. https://doi.org/10.1038/s41537-020-0102-z

Zhang, B., Han, M., Tan, S. et al. Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients. Sci Rep 7, 11821 (2017). https://doi.org/10.1038/s41598-017-12027-w

Häfner, H. (2019). From onset and prodromal stage to a life-long course of schizophrenia and its symptom dimensions: how sex, age, and other risk factors influence incidence and course of illness. Psychiatry journal, 2019. https://doi.org/10.1155/2019/9804836

Dorofeikova, M., Neznanov, N., & Petrova, N. (2018). Cognitive deficit in patients with paranoid schizophrenia: its clinical and laboratory correlates. Psychiatry research, 262, 542-548. https://doi.org/10.1016/j.psychres.2017.09.041

Hakulinen, C., McGrath, J. J., Timmerman, A., Skipper, N., Mortensen, P. B., Pedersen, C. B., & Agerbo, E. (2019). The association between early-onset schizophrenia with employment, income, education, and cohabitation status: nationwide study with 35 years of follow-up. Social Psychiatry and Psychiatric Epidemiology, 54, 1343-1351. https://doi.org/10.1007/s00127-019-01756-0

Hakulinen, C., Elovainio, M., Arffman, M., Lumme, S., Suokas, K., Pirkola, S., ... & Böckerman, P. (2020). Employment status and personal income before and after onset of a severe mental disorder: a case-control study. Psychiatric services, 71(3), 250-255. https://doi.org/10.1176/appi.ps.201900239

Kaar, S. J., Natesan, S., Mccutcheon, R., & Howes, O. D. (2020). Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology, 172, 107704. https://doi.org/10.1016/j.neuropharm.2019.107704

Martínez, A. L., Brea, J., Rico, S., De los Frailes, M. T., & Loza, M. I. (2021). Cognitive deficit in schizophrenia: from etiology to novel treatments. International Journal of Molecular Sciences, 22(18), 9905. https://doi.org/10.3390/ijms22189905

Fernandes, T. P., Shaqiri, A., Brand, A., Nogueira, R. L., Herzog, M. H., Roinishvili, M., ... & Chkonia, E. (2019). Schizophrenia patients using atypical medication perform better in visual tasks than patients using typical medication. Psychiatry research, 275, 31-38. https://doi.org/10.1016/j.psychres.2019.03.008

Baldez, D. P., Biazus, T. B., Rabelo-da-Ponte, F. D., Nogaro, G. P., Martins, D. S., Kunz, M., & Czepielewski, L. S. (2021). The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: network meta-analyses of randomized controlled trials. Neuroscience & Biobehavioral Reviews, 126, 265-275. https://doi.org/10.1016/j.neubiorev.2021.03.028

Yang, Y., Liu, Y., Wang, G., Hei, G., Wang, X., Li, R., ... & Zhao, J. (2019). Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia. Psychiatry Research, 273, 528-536. https://doi.org/10.1016/j.psychres.2019.01.051